| PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes (NCT06091267) | Otsuka Beijing Research Institute | 2023-10-16 |
| Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type (NCT05923892) | Otsuka Beijing Research Institute | 2023-08-02 |
| To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD (NCT05650320) | Otsuka Beijing Research Institute | 2023-02-17 |
| To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD (NCT05667623) | Otsuka Beijing Research Institute | 2023-02-06 |
| Safety and Tolerability, and PK of Sibeprenlimab in Chinese Healthy Subject (NCT07105124) | Otsuka Beijing Research Institute | 2022-10-18 |
| OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects (NCT05583474) | Otsuka Beijing Research Institute | 2022-09-27 |
| OPC-61815 in Healthy Chinese Male Subjects (NCT05439148) | Otsuka Beijing Research Institute | 2022-06-30 |
| The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation (NCT04233346) | Otsuka Beijing Research Institute | 2020-07-09 |
| Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia (NCT03874494) | Otsuka Beijing Research Institute | 2019-11-27 |
| The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects (NCT03734302) | Otsuka Beijing Research Institute | 2019-04-24 |
| The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects (NCT03734354) | Otsuka Beijing Research Institute | 2019-04-07 |
| PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia (NCT03285503) | Otsuka Beijing Research Institute | 2018-08-17 |
| The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder (NCT03487198) | Otsuka Beijing Research Institute | 2018-05-30 |
| Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome (NCT03487783) | Otsuka Beijing Research Institute | 2018-05-02 |
| Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder (NCT03487770) | Otsuka Beijing Research Institute | 2018-04-09 |